Table II from Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review. | Semantic Scholar
Pharmaceuticals | Free Full-Text | Therapeutic Potential of Kappa Opioid Agonists
κ-Opioid Receptor (KOP) | 7TM Antibodies
Kappa Opiate Receptor - an overview | ScienceDirect Topics
Structure–activity relationship investigation of triazole-based kappa opioid receptor agonists | SpringerLink
Effects of Kappa Opioid Agonists on Cocaine- and Food-Maintained Responding by Rhesus Monkeys | Journal of Pharmacology and Experimental Therapeutics
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
Development of κ opioid receptor antagonists. | Semantic Scholar
Kappa opioids inhibit the GABA/glycine terminals of rostral ventromedial medulla projections in the superficial dorsal horn of the spinal cord - Otsu - 2022 - The Journal of Physiology - Wiley Online Library
A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics - ScienceDirect
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Kappa Receptors – Opioid Peptides
Opioids in cancer: The κ‑opioid receptor (Review)
New Kappa-Opioid Receptor Agonist Curbs Pain, Avoids Side Effects
Diverse Kappa Opioid Receptor Agonists: Relationships Between Signaling and Behavior
Representative examples of common scaffolds in kappa opioid receptor... | Download Scientific Diagram
κ-opioid receptor - Wikipedia
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports
Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy | ACS Chemical Neuroscience
Opioids: classification, uses, action and dependence - MedicalVerge
BRL 52537 hydrochloride, kappa-opioid agonist (CAS 112282-24-3) (ab120669)
Opioid kappa receptor agonists - Pipeline Insight, 2022
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
Cara Therapeutics: Scratching An Itch Left Unscratched (NASDAQ:CARA) | Seeking Alpha
